According to research published online in the Annals of Rheumatic Diseases, people who suffer from atopic (allergic) diseases like asthma or eczema may be more likely to develop osteoarthritis, a painful and frequently disabling condition of the joints.
The researchers suggest that medications that reduce the body’s physiological triggers for allergic reactions may mitigate this risk.
An Overview
Osteoarthritis is the most widespread type of arthritis. However, despite the disease’s high prevalence, high costs, and crippling effects, there is currently no effective treatment. The accurate management of symptoms is the primary focus of treatment.
One hundred seventeen thousand three hundred forty-six individuals with allergic asthma or eczema, averaging 52; 60 percent of them were women) and 1,247,196 healthy people (average age 50; The insurance claims database contained 48% women’s names.
Over an average of eight years, those with allergic asthma or eczema had a 58% higher risk of developing osteoarthritis than those without the condition. In other words, if 100 people with and without atopic disease were followed for ten years, there would be 27 new cases compared to 19 new patients.
End Note
This trend was even more pronounced among the 4,325 individuals who suffered from both allergic asthma and eczema: They were twice as likely as people without atopic disease to develop osteoarthritis.
| Read More news: Click here |
